Health Care & Life Sciences » Pharmaceuticals | Relmada Therapeutics Inc.

Relmada Therapeutics Inc. | Key People and Executives

Sergio Traversa
CEO, CFO, Principal Accounting Officer & Director
Charles J. Casamento
Chairman
Paul Kelly
Independent Director
Maged S. Shenouda
Independent Director
Sergio Traversa
CEO, CFO, Principal Accounting Officer & Director
Ottavio V. Vitolo
Chief Medical Officer & Senior Vice President
Michael D. Becker
Senior VP-Finance & Corporate Development
Charles J. Casamento
Chairman
Paul Kelly
Independent Director
Maged S. Shenouda
Independent Director

About Relmada Therapeutics

View Profile
Address
880 Third Avenue
New York New York 10022
United States
Employees -
Website http://www.relmada.com
Updated 07/08/2019
Relmada Therapeutics, Inc. is a clinical-stage and biotechnology company, which engages in developing drug products together with new chemical entities that address areas of unmet medical need in the treatment of central nervous system diseases. Its portfolio of products include d-Methadone, LevoCap ER, BuTab REL-1028, and MepiGel REL-1021. The company was founded on May 31, 2012 and is headquartered in New York, NY.